← All sarcoma trials
Opening soonN/AAges 18 Years and up

Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy

Sponsor: University Medical Center Groningen · NCT06726512 on ClinicalTrials.gov ↗

Conditions studied

Oral CancerOsteosarcomaSoft Tissue SarcomaOral Squamous Cell Carcinoma (OSCC)

What it tests

  • XEOS AURA 10device

Where it's running1 site

1 international site
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Age ≥18 years.
* Patient is confirmed with oral squamous cell carcinoma, soft tissue sarcoma or osteosarcoma.
* Patient is indicated to undergo curative surgery of the primary tumor.
* Patient is estimated compliant for study participation by the investigator.
* Written informed consent.

Exclusion Criteria:

* Medical or psychiatric conditions that compromise the patient's ability to give informed consent;
* Patient has previously received radiotherapy of the primary tumor region;
* Patient has participated in other clinical studies with radiation exposure of more than 1 mSv in the past 12 months;
* A blood glucose level over 200 mg/dL on the day of surgery.
* Pregnancy or lactation.

Updated 2024-12-10 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.